Alan Richardson

Keele University

H-index: 28

Europe-United Kingdom

About Alan Richardson

Alan Richardson, With an exceptional h-index of 28 and a recent h-index of 17 (since 2020), a distinguished researcher at Keele University, specializes in the field of Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models

Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2

Rapid changes in the ATG5‐ATG16L1 complex following nutrient deprivation measured using NanoLuc Binary Technology (NanoBIT)

Alan Richardson Information

University	Keele University
Position	Reader in Pharmacology
Citations(all)	3711
Citations(since 2020)	709
Cited By	3065
hIndex(all)	28
hIndex(since 2020)	17
i10Index(all)	44
i10Index(since 2020)	24
Email	Access Email
University Profile Page	Keele University
Google Scholar	View Google Scholar Profile

Alan Richardson Skills & Research Interests

Cancer

Alan Richardson

Keele University

About Alan Richardson

Alan Richardson Information

Alan Richardson Skills & Research Interests

Top articles of Alan Richardson

The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models

Scott P Davies

Richard Karlsson

Ieva Bagdonaite

Zania Stamataki

Zhang Yang

Alan Richardson

Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2

Mark Skidmore

Farhat Khanim

Alan Richardson

Rapid changes in the ATG5‐ATG16L1 complex following nutrient deprivation measured using NanoLuc Binary Technology (NanoBIT)

Euphemia Leung

Jóhannes Reynisson

Alan Richardson